Talbot; Adam Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for Talbot; Adam Charles.The latest application filed is for "inhibiting ubiquitin specific peptidase 9x".

Company Profile

27.21.28

Talbot; Adam Charles - Watertown MA
Talbot; Adam Charles - Guilford CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibiting Ubiquitin Specific Peptidase 9x App 20220041597 - Follows; Bruce ; et al.	2022-02-10
Pyrrolotriazinones And Imidazotriazinones As Ubiquitin-specific Protease 7 Inhibitors App 20220033403 - Ioannidis; Stephanos ; et al.	2022-02-03
Inhibiting Ubiquitin Specific Peptidase 9x App 20210346356 - LYNES; Maureen ; et al.	2021-11-11
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20210332052 - Ioannidis; Stephanos ; et al.	2021-10-28
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20210323978 - Ioannidis; Stephanos ; et al.	2021-10-21
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20210292337 - Ioannidis; Stephanos ; et al.	2021-09-23
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20210130321 - Ioannidis; Stephanos ; et al.	2021-05-06
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors Grant 10,981,915 - Ioannidis , et al. April 20, 2	2021-04-20
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 10,934,299 - Ioannidis , et al. March 2, 2	2021-03-02
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors Grant 10,927,130 - Ioannidis , et al. February 23, 2	2021-02-23
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors Grant 10,906,916 - Ioannidis , et al. February 2, 2	2021-02-02
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,836,741 - Ioannidis , et al. November 17, 2	2020-11-17
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20200087280 - Ioannidis; Stephanos ; et al.	2020-03-19
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,519,127 - Ioannidis , et al. Dec	2019-12-31
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,519,129 - Ioannidis , et al. Dec	2019-12-31
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,519,130 - Ioannidis , et al. Dec	2019-12-31
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,519,128 - Ioannidis , et al. Dec	2019-12-31
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,513,508 - Ioannidis , et al. Dec	2019-12-24
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,513,507 - Ioannidis , et al. Dec	2019-12-24
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,508,098 - Ioannidis , et al. Dec	2019-12-17
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20190367525 - Ioannidis; Stephanos ; et al.	2019-12-05
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20190359629 - Ioannidis; Stephanos ; et al.	2019-11-28
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20190359635 - Ioannidis; Stephanos ; et al.	2019-11-28
Pyrrolotriazinones And Imidazotriazinones As Ubiquitin-specific Protease 7 Inhibitors App 20190308980 - Ioannidis; Stephanos ; et al.	2019-10-10
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors Grant 10,377,773 - Ioannidis , et al. A	2019-08-13
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 10,377,760 - Ioannidis , et al. A	2019-08-13
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors Grant 10,377,767 - Ioannidis , et al. A	2019-08-13
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors Grant 10,351,571 - Ioannidis , et al. July 16, 2	2019-07-16
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20190071420 - Ioannidis; Stephanos ; et al.	2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20190071419 - Ioannidis; Stephanos ; et al.	2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20190071421 - Ioannidis; Stephanos ; et al.	2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20190071422 - Ioannidis; Stephanos ; et al.	2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20190071418 - Ioannidis; Stephanos ; et al.	2019-03-07
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20190071423 - Ioannidis; Stephanos ; et al.	2019-03-07
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20180346480 - Ioannidis; Stephanos ; et al.	2018-12-06
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20180346485 - Ioannidis; Stephanos ; et al.	2018-12-06
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20180339988 - Ioannidis; Stephanos ; et al.	2018-11-29
Pyrrolotriazinones And Imidazotriazinones As Ubiquitin-specific Protease 7 Inhibitors App 20180339991 - Ioannidis; Stephanos ; et al.	2018-11-29
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors Grant 10,000,495 - Ioannidis , et al. June 19, 2	2018-06-19
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20180162835 - Ioannidis; Stephanos ; et al.	2018-06-14
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors Grant 9,938,300 - Ioannidis , et al. April 10, 2	2018-04-10
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors Grant 9,932,351 - Ioannidis , et al. April 3, 2	2018-04-03
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 9,902,728 - Ioannidis , et al. February 27, 2	2018-02-27
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 9,840,491 - Ioannidis , et al. December 12, 2	2017-12-12
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20160229872 - Ioannidis; Stephanos ; et al.	2016-08-11
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20160229864 - Ioannidis; Stephanos ; et al.	2016-08-11
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20160229833 - Ioannidis; Stephanos ; et al.	2016-08-11
Pyrrolotriazinones And Imidazotriazinones As Ubiquitin-specific Protease 7 Inhibitors App 20160185786 - Ioannidis; Stephanos ; et al.	2016-06-30
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20160185785 - Ioannidis; Stephanos ; et al.	2016-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.